Using the software «DAWN AC» for control of dosing warfarin in the special anticoagulation clinics
https://doi.org/10.24884/1607-4181-2015-22-2-32-35
Abstract
Warfarin remains the drug of choice for the prevention of ischemic stroke, thus optimization of methods of control of dosing this preparation becomes more topical. The aim of our study was to test computer software for monitoring anticoagulant therapy with warfarin in patients with atrial fibrillation based on the day anticoagulant hospital. A total of 6 people with atrial fibrillation undergoing treatment with warfarin in specialized outpatient clinics were monitored with the software for 3 to 6 months. At the same time, comparable 11 patients with atrial fibrillation were followed by experienced clinician. Both groups were matched by sex, age and clinical diagnosis. The comparison group consisted of 11 patients diagnosed with the same disease, of the same gender and age. We have found that in patients followed by anticoagulation software the time spent in the therapeutic INR range was twice the time in therapeutic range of patients in which the dosing and follow-up was done by experienced doctor (p<0.05). The data indicate the possibility of using software to monitor warfarin therapy, which increases the clinical safety of its use.
About the Authors
O. S. Napalkova
Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова; Северо-западный федеральный исследовательский медицинский центр
Russian Federation
Russian Federation
V. L. Emanuel
Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова; Северо-западный федеральный исследовательский медицинский центр
Russian Federation
Russian Federation
M. A. Karpenko
Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова; Северо-западный федеральный исследовательский медицинский центр
Russian Federation
Russian Federation
S. V. Lapin
Первый Санкт-Петербургский государственный медицинский университет имени академика И. П. Павлова; Северо-западный федеральный исследовательский медицинский центр
Russian Federation
Russian Federation
References
1. Кропачева Е. С. Обеспечение безопастности длительной терапии варфарином: возможно ли возобновить лечение больного после гемморагического осложнения? // Рациональная фармокотерапия в кардиол. - 2009. - № 3.
2. Хруслов М. В., Уханова И. Ю., Лобачев В. И. Оценка эффективности системы централизованного мониторинга лечения варфарином // Трудный пациент. - 2013.
3. Ageno W., Johnson J. et al. A computer generated induction system for hospitalized patients starting on oral anticoagulant therapy // Thromb Haemost. - 2000. - Vol. 83. - № 6. - Р. 849 - 852.
4. Connolly S. J., Pogue J. et al. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range // Circulation. - 2008. - Vol. 118. - № 20. - P. 2029 - 2037.
5. Fuster V., Ryden L. E. et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) // Eur. Heart J. - 2006. - Vol. 27. - № 16. - P. 1979 - 2030.
6. Holbrook A., Schulman S. et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis. - 9th ed. // American College of Chest // Physicians Evidence-Based Clinical Practice Guidelines. Chest. - 2012. - Vol. 141 (Suppl. 2). - P. 152S - 184S.
7. Jowett S., Bryan S. et al. The cost-effectiveness of computer-assisted anticoagulant dosage: results from the European Action on Anticoagulation (EAA) multicentre study // J. Thromb. Haemost. - 2009. - Vol. 7. - № 9. - P. 1482-1490.
8. Lader E., Martin N. et al. Warfarin therapeutic monitoring: is 70% time in the therapeutic range the best we can do? // J. Clin. Pharm. Ther. - 2012. - Vol. 37 (4). - Р. 375 - 377.
9. Mitra R., Marciello M. A. et al. Efficacy of computer-aided dosing of warfarin among patients in a rehabilitation hospital // Am. J. Phys. Med. Rehabil. - 2005. - Vol. 84. - № 6. - P. 423 - 427.
10. Poller L., Keown M. et al. An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage // J. Thromb Haemost. - 2008. - Vol. 6. - № 6. - P. 935 - 943.
11. Poller L., Keown M. et al. A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program // Thromb. Haemost. - 2009. - Vol. 101. - № 3. - P. 487 - 494.
12. Rosendaal F. R., Cannegieter S. C. et al. A method to determine the optimal intensity of oral anticoagulant therapy // Thromb. Haemost. - 1993. - Vol. 69. - № 3. - P. 236 - 239.
Review
For citations:
Napalkova O.S., Emanuel V.L., Karpenko M.A., Lapin S.V. Using the software «DAWN AC» for control of dosing warfarin in the special anticoagulation clinics. The Scientific Notes of the Pavlov University. 2015;22(2):32-35. (In Russ.) https://doi.org/10.24884/1607-4181-2015-22-2-32-35
Views:
804
Email this article 